The common, over-the-counter anti-inflammatory ibuprofen could boost bone
repair in patients who undergo surgery.
According to new research conducted at the University of Granada and
published in the Journal of Bone and Mineral Metabolism, the non-steroidal drug
could also be beneficial for fracture patients.
The researchers found that unlike other anti-inflammatories, the drug does
not have a negative impact on the synthesis of osteoblast osteocalcin, which
plays a major role in bone repair.
Concepcion Ruiz Rodriguez, a professor at the university's nursing
department, noted: "[So far], we [have] had little information on the
effects of ibuprofen on osteoblast cells."
The International Osteoprosis Foundation recently highlighted that the risk
of hip fracture appears to be linked to bone mass reduction in the joint.
A study at the Steadman-Philippon Research Institute said that the risk of
complications during the treatment of hip disorders increases significantly in
patients over the age of 35.
Private treatment news: 5 July 2012
